Jones Financial Companies
CVAC

Jones Financial Companies’s CureVac CVAC Stock Holding History

Jones Financial Companies’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25
Closed -$134 – 4444
2025
Q3 		$134 Hold
25
– – ﹤0.01% 4147
2025
Q2 		$135 Hold
25
– – ﹤0.01% 3936
2025
Q1 		$75 Hold
25
– – ﹤0.01% 3638
2024
Q4 		$85 Hold
25
– – ﹤0.01% 3360
2024
Q3 		$75 Hold
25
– – ﹤0.01% 2980
2024
Q2 		$85 Buy
+25
New +$82 ﹤0.01% 2398

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jones Financial Companies's CVAC Position: Q4 2025 in Review

Jones Financial Companies sold out of CureVac (CVAC) in Q4 2025, closing a stake of 25 shares — an estimated $134 sold.

Jones Financial Companies first reported a position in CVAC in Q2 2024 and held it in 6 quarters. The position peaked at $135 in Q2 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Jones Financial Companies reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Jones Financial Companies sold 25 CureVac shares in Q4 2025, an estimated $134.
  • Jones Financial Companies first reported a position in CureVac in Q2 2024 and held it in 6 quarters.
  • Jones Financial Companies's CureVac position peaked at $135 in Q2 2025.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.